Brazil vigilance revamp means stronger powers
This article was originally published in Clinica
Executive Summary
Brazil is planning to revamp its healthcare vigilance and post-market surveillance activities with the creation of the Vigipos adverse event reporting and investigation system. According to proposals published by Anvisa in the Diario Oficial da Uniao (DOU) of March 31 for public consultation, the move seeks to strengthen the data collection activities of healthcare providers and pathology laboratories alike in each state, to investigate adverse events and technical complaints and then re-integrate the findings into the system, at all levels of the health service (SUS).